Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for JUN
Z-value: 1.46
Motif logo
Transcription factors associated with JUN
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
JUN
|
ENSG00000177606.5 | Jun proto-oncogene, AP-1 transcription factor subunit |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| JUN | hg19_v2_chr1_-_59249732_59249785 | -0.43 | 1.7e-02 | Click! |
Activity profile of JUN motif
Sorted Z-values of JUN motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr17_-_76899275 | 9.47 |
ENST00000322630.2
ENST00000586713.1 |
DDC8
|
Protein DDC8 homolog |
| chr19_-_51014345 | 7.42 |
ENST00000391815.3
ENST00000594350.1 ENST00000601423.1 |
JOSD2
|
Josephin domain containing 2 |
| chr2_-_216300784 | 7.38 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
| chr14_+_68086515 | 7.00 |
ENST00000261783.3
|
ARG2
|
arginase 2 |
| chr8_-_10697281 | 6.97 |
ENST00000524114.1
ENST00000553390.1 ENST00000554914.1 |
PINX1
SOX7
SOX7
|
PIN2/TERF1 interacting, telomerase inhibitor 1 SRY (sex determining region Y)-box 7 Transcription factor SOX-7; Uncharacterized protein; cDNA FLJ58508, highly similar to Transcription factor SOX-7 |
| chr4_+_75310851 | 6.22 |
ENST00000395748.3
ENST00000264487.2 |
AREG
|
amphiregulin |
| chr4_+_75311019 | 6.03 |
ENST00000502307.1
|
AREG
|
amphiregulin |
| chr1_+_17531614 | 5.82 |
ENST00000375471.4
|
PADI1
|
peptidyl arginine deiminase, type I |
| chr19_-_51014460 | 5.80 |
ENST00000595669.1
|
JOSD2
|
Josephin domain containing 2 |
| chr1_+_152956549 | 5.54 |
ENST00000307122.2
|
SPRR1A
|
small proline-rich protein 1A |
| chr2_-_216257849 | 5.38 |
ENST00000456923.1
|
FN1
|
fibronectin 1 |
| chr20_+_34203794 | 5.23 |
ENST00000374273.3
|
SPAG4
|
sperm associated antigen 4 |
| chr7_+_5632436 | 4.78 |
ENST00000340250.6
ENST00000382361.3 |
FSCN1
|
fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) |
| chr1_+_151030234 | 4.53 |
ENST00000368921.3
|
MLLT11
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11 |
| chr4_+_75480629 | 4.50 |
ENST00000380846.3
|
AREGB
|
amphiregulin B |
| chr1_+_152974218 | 4.42 |
ENST00000331860.3
ENST00000443178.1 ENST00000295367.4 |
SPRR3
|
small proline-rich protein 3 |
| chr4_-_122744998 | 4.40 |
ENST00000274026.5
|
CCNA2
|
cyclin A2 |
| chr14_-_24732368 | 4.26 |
ENST00000544573.1
|
TGM1
|
transglutaminase 1 |
| chr14_-_24732403 | 4.07 |
ENST00000206765.6
|
TGM1
|
transglutaminase 1 |
| chr2_+_70142232 | 3.91 |
ENST00000540449.1
|
MXD1
|
MAX dimerization protein 1 |
| chr2_+_11864458 | 3.68 |
ENST00000396098.1
ENST00000396099.1 ENST00000425416.2 |
LPIN1
|
lipin 1 |
| chr15_-_91537723 | 3.55 |
ENST00000394249.3
ENST00000559811.1 ENST00000442656.2 ENST00000557905.1 ENST00000361919.3 |
PRC1
|
protein regulator of cytokinesis 1 |
| chr19_+_54371114 | 3.52 |
ENST00000448420.1
ENST00000439000.1 ENST00000391770.4 ENST00000391771.1 |
MYADM
|
myeloid-associated differentiation marker |
| chr19_-_51014588 | 3.43 |
ENST00000598418.1
|
JOSD2
|
Josephin domain containing 2 |
| chrX_-_153602991 | 3.42 |
ENST00000369850.3
ENST00000422373.1 |
FLNA
|
filamin A, alpha |
| chr16_+_11343475 | 3.41 |
ENST00000572173.1
|
RMI2
|
RecQ mediated genome instability 2 |
| chr9_+_75229616 | 3.23 |
ENST00000340019.3
|
TMC1
|
transmembrane channel-like 1 |
| chr17_-_43209862 | 3.13 |
ENST00000322765.5
|
PLCD3
|
phospholipase C, delta 3 |
| chr21_-_44846999 | 3.10 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
| chr1_-_204121102 | 3.09 |
ENST00000367202.4
|
ETNK2
|
ethanolamine kinase 2 |
| chr2_-_190044480 | 3.07 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
| chr8_-_41522719 | 3.06 |
ENST00000335651.6
|
ANK1
|
ankyrin 1, erythrocytic |
| chr1_-_204121298 | 3.00 |
ENST00000367199.2
|
ETNK2
|
ethanolamine kinase 2 |
| chr9_+_34990219 | 2.98 |
ENST00000541010.1
ENST00000454002.2 ENST00000545841.1 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
| chr11_-_28129656 | 2.96 |
ENST00000263181.6
|
KIF18A
|
kinesin family member 18A |
| chr19_-_19051993 | 2.94 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
| chr17_+_40610862 | 2.93 |
ENST00000393829.2
ENST00000546249.1 ENST00000537728.1 ENST00000264649.6 ENST00000585525.1 ENST00000343619.4 ENST00000544137.1 ENST00000589727.1 ENST00000587824.1 |
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1 |
| chr11_+_33061543 | 2.92 |
ENST00000432887.1
ENST00000528898.1 ENST00000531632.2 |
TCP11L1
|
t-complex 11, testis-specific-like 1 |
| chr15_-_63674034 | 2.91 |
ENST00000344366.3
ENST00000422263.2 |
CA12
|
carbonic anhydrase XII |
| chr7_-_41742697 | 2.87 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
| chr20_-_44420507 | 2.84 |
ENST00000243938.4
|
WFDC3
|
WAP four-disulfide core domain 3 |
| chr4_-_104119528 | 2.82 |
ENST00000380026.3
ENST00000503705.1 ENST00000265148.3 |
CENPE
|
centromere protein E, 312kDa |
| chr9_+_34989638 | 2.80 |
ENST00000453597.3
ENST00000335998.3 ENST00000312316.5 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
| chr17_+_41476327 | 2.79 |
ENST00000320033.4
|
ARL4D
|
ADP-ribosylation factor-like 4D |
| chr1_-_204121013 | 2.79 |
ENST00000367201.3
|
ETNK2
|
ethanolamine kinase 2 |
| chr6_-_53213587 | 2.76 |
ENST00000542638.1
ENST00000370913.5 ENST00000541407.1 |
ELOVL5
|
ELOVL fatty acid elongase 5 |
| chr12_+_48876275 | 2.74 |
ENST00000314014.2
|
C12orf54
|
chromosome 12 open reading frame 54 |
| chr5_+_147691979 | 2.72 |
ENST00000274565.4
|
SPINK7
|
serine peptidase inhibitor, Kazal type 7 (putative) |
| chrX_+_49832231 | 2.71 |
ENST00000376108.3
|
CLCN5
|
chloride channel, voltage-sensitive 5 |
| chr9_+_105757590 | 2.70 |
ENST00000374798.3
ENST00000487798.1 |
CYLC2
|
cylicin, basic protein of sperm head cytoskeleton 2 |
| chr2_-_238322770 | 2.69 |
ENST00000472056.1
|
COL6A3
|
collagen, type VI, alpha 3 |
| chr16_-_4588762 | 2.67 |
ENST00000562334.1
ENST00000562579.1 ENST00000567695.1 ENST00000563507.1 |
CDIP1
|
cell death-inducing p53 target 1 |
| chr8_-_125740514 | 2.65 |
ENST00000325064.5
ENST00000518547.1 |
MTSS1
|
metastasis suppressor 1 |
| chr10_-_3827417 | 2.63 |
ENST00000497571.1
ENST00000542957.1 |
KLF6
|
Kruppel-like factor 6 |
| chr7_-_142247606 | 2.62 |
ENST00000390361.3
|
TRBV7-3
|
T cell receptor beta variable 7-3 |
| chr2_-_238323007 | 2.62 |
ENST00000295550.4
|
COL6A3
|
collagen, type VI, alpha 3 |
| chr7_-_45128472 | 2.61 |
ENST00000490531.2
|
NACAD
|
NAC alpha domain containing |
| chr2_-_238322800 | 2.60 |
ENST00000392004.3
ENST00000433762.1 ENST00000347401.3 ENST00000353578.4 ENST00000346358.4 ENST00000392003.2 |
COL6A3
|
collagen, type VI, alpha 3 |
| chr19_+_16187085 | 2.56 |
ENST00000300933.4
|
TPM4
|
tropomyosin 4 |
| chr2_+_37571717 | 2.54 |
ENST00000338415.3
ENST00000404976.1 |
QPCT
|
glutaminyl-peptide cyclotransferase |
| chr22_+_38597889 | 2.52 |
ENST00000338483.2
ENST00000538320.1 ENST00000538999.1 ENST00000441709.1 |
MAFF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
| chr2_+_37571845 | 2.45 |
ENST00000537448.1
|
QPCT
|
glutaminyl-peptide cyclotransferase |
| chr4_+_1873100 | 2.42 |
ENST00000508803.1
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1 |
| chr7_-_140624499 | 2.38 |
ENST00000288602.6
|
BRAF
|
v-raf murine sarcoma viral oncogene homolog B |
| chr3_-_48130707 | 2.37 |
ENST00000360240.6
ENST00000383737.4 |
MAP4
|
microtubule-associated protein 4 |
| chr9_-_131644202 | 2.37 |
ENST00000320665.6
ENST00000436267.2 |
CCBL1
|
cysteine conjugate-beta lyase, cytoplasmic |
| chr7_-_129592471 | 2.37 |
ENST00000473814.2
ENST00000490974.1 |
UBE2H
|
ubiquitin-conjugating enzyme E2H |
| chr20_+_42295745 | 2.34 |
ENST00000396863.4
ENST00000217026.4 |
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
| chr3_+_38206975 | 2.31 |
ENST00000446845.1
ENST00000311806.3 |
OXSR1
|
oxidative stress responsive 1 |
| chr9_-_131644306 | 2.29 |
ENST00000302586.3
|
CCBL1
|
cysteine conjugate-beta lyase, cytoplasmic |
| chr16_-_4588822 | 2.27 |
ENST00000564828.1
|
CDIP1
|
cell death-inducing p53 target 1 |
| chr3_+_52350335 | 2.26 |
ENST00000420323.2
|
DNAH1
|
dynein, axonemal, heavy chain 1 |
| chr19_-_52227221 | 2.22 |
ENST00000222115.1
ENST00000540069.2 |
HAS1
|
hyaluronan synthase 1 |
| chr11_-_119599794 | 2.20 |
ENST00000264025.3
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
| chr11_-_2160180 | 2.19 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr13_-_60737898 | 2.17 |
ENST00000377908.2
ENST00000400319.1 ENST00000400320.1 ENST00000267215.4 |
DIAPH3
|
diaphanous-related formin 3 |
| chr2_+_70142189 | 2.17 |
ENST00000264444.2
|
MXD1
|
MAX dimerization protein 1 |
| chr21_+_39628852 | 2.14 |
ENST00000398938.2
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
| chr2_+_54785485 | 2.13 |
ENST00000333896.5
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1 |
| chr22_+_22988816 | 2.12 |
ENST00000480559.1
ENST00000448514.1 |
GGTLC2
|
gamma-glutamyltransferase light chain 2 |
| chr9_+_116298778 | 2.12 |
ENST00000462143.1
|
RGS3
|
regulator of G-protein signaling 3 |
| chr8_-_125740730 | 2.07 |
ENST00000354184.4
|
MTSS1
|
metastasis suppressor 1 |
| chr11_-_64647144 | 2.06 |
ENST00000359393.2
ENST00000433803.1 ENST00000411683.1 |
EHD1
|
EH-domain containing 1 |
| chr15_-_63674218 | 2.02 |
ENST00000178638.3
|
CA12
|
carbonic anhydrase XII |
| chr9_+_131644398 | 2.00 |
ENST00000372599.3
|
LRRC8A
|
leucine rich repeat containing 8 family, member A |
| chr20_-_1306351 | 1.99 |
ENST00000381812.1
|
SDCBP2
|
syndecan binding protein (syntenin) 2 |
| chr12_-_48164812 | 1.97 |
ENST00000549151.1
ENST00000548919.1 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
| chr12_+_56521840 | 1.95 |
ENST00000394048.5
|
ESYT1
|
extended synaptotagmin-like protein 1 |
| chr5_-_172198190 | 1.93 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
| chr12_+_113344755 | 1.93 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
| chr7_+_142031986 | 1.92 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
| chr11_-_119187826 | 1.92 |
ENST00000264036.4
|
MCAM
|
melanoma cell adhesion molecule |
| chr20_-_1306391 | 1.90 |
ENST00000339987.3
|
SDCBP2
|
syndecan binding protein (syntenin) 2 |
| chr22_+_25003626 | 1.87 |
ENST00000451366.1
ENST00000406383.2 ENST00000428855.1 |
GGT1
|
gamma-glutamyltransferase 1 |
| chr9_+_131644388 | 1.86 |
ENST00000372600.4
|
LRRC8A
|
leucine rich repeat containing 8 family, member A |
| chr19_+_16186903 | 1.86 |
ENST00000588507.1
|
TPM4
|
tropomyosin 4 |
| chr17_+_33914460 | 1.84 |
ENST00000537622.2
|
AP2B1
|
adaptor-related protein complex 2, beta 1 subunit |
| chr11_+_57310114 | 1.83 |
ENST00000527972.1
ENST00000399154.2 |
SMTNL1
|
smoothelin-like 1 |
| chr1_+_64669294 | 1.83 |
ENST00000371077.5
|
UBE2U
|
ubiquitin-conjugating enzyme E2U (putative) |
| chr16_+_81040794 | 1.82 |
ENST00000439957.3
ENST00000393335.3 ENST00000428963.2 ENST00000564669.1 |
CENPN
|
centromere protein N |
| chr4_+_86525299 | 1.82 |
ENST00000512201.1
|
ARHGAP24
|
Rho GTPase activating protein 24 |
| chr16_-_4588469 | 1.82 |
ENST00000588381.1
ENST00000563332.2 |
CDIP1
|
cell death-inducing p53 target 1 |
| chr3_+_10068095 | 1.81 |
ENST00000287647.3
ENST00000383807.1 ENST00000383806.1 ENST00000419585.1 |
FANCD2
|
Fanconi anemia, complementation group D2 |
| chr20_+_43343886 | 1.81 |
ENST00000190983.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr9_+_131644781 | 1.81 |
ENST00000259324.5
|
LRRC8A
|
leucine rich repeat containing 8 family, member A |
| chr19_+_36024310 | 1.81 |
ENST00000222286.4
|
GAPDHS
|
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic |
| chr14_+_96722539 | 1.80 |
ENST00000553356.1
|
BDKRB1
|
bradykinin receptor B1 |
| chr14_-_35182994 | 1.79 |
ENST00000341223.3
|
CFL2
|
cofilin 2 (muscle) |
| chr3_-_48130314 | 1.77 |
ENST00000439356.1
ENST00000395734.3 ENST00000426837.2 |
MAP4
|
microtubule-associated protein 4 |
| chr19_+_17666403 | 1.76 |
ENST00000252599.4
|
COLGALT1
|
collagen beta(1-O)galactosyltransferase 1 |
| chrX_+_152953505 | 1.75 |
ENST00000253122.5
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8 |
| chr6_+_121756809 | 1.74 |
ENST00000282561.3
|
GJA1
|
gap junction protein, alpha 1, 43kDa |
| chr7_+_151653464 | 1.74 |
ENST00000431418.2
ENST00000392800.2 |
GALNTL5
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5 |
| chr2_-_220408430 | 1.73 |
ENST00000243776.6
|
CHPF
|
chondroitin polymerizing factor |
| chr19_+_42772659 | 1.72 |
ENST00000572681.2
|
CIC
|
capicua transcriptional repressor |
| chr1_-_6453399 | 1.70 |
ENST00000608083.1
|
ACOT7
|
acyl-CoA thioesterase 7 |
| chr17_+_33914276 | 1.70 |
ENST00000592545.1
ENST00000538556.1 ENST00000312678.8 ENST00000589344.1 |
AP2B1
|
adaptor-related protein complex 2, beta 1 subunit |
| chr20_+_44420570 | 1.67 |
ENST00000372622.3
|
DNTTIP1
|
deoxynucleotidyltransferase, terminal, interacting protein 1 |
| chr3_-_50374869 | 1.67 |
ENST00000327761.3
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1 |
| chr7_-_142120321 | 1.66 |
ENST00000390377.1
|
TRBV7-7
|
T cell receptor beta variable 7-7 |
| chr22_-_38713428 | 1.66 |
ENST00000403904.1
ENST00000405675.3 |
CSNK1E
|
casein kinase 1, epsilon |
| chr6_+_28048753 | 1.64 |
ENST00000377325.1
|
ZNF165
|
zinc finger protein 165 |
| chr16_-_79634595 | 1.64 |
ENST00000326043.4
ENST00000393350.1 |
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
| chr1_-_6453426 | 1.63 |
ENST00000545482.1
|
ACOT7
|
acyl-CoA thioesterase 7 |
| chr12_-_12715266 | 1.62 |
ENST00000228862.2
|
DUSP16
|
dual specificity phosphatase 16 |
| chr2_-_202645612 | 1.60 |
ENST00000409632.2
ENST00000410052.1 ENST00000467448.1 |
ALS2
|
amyotrophic lateral sclerosis 2 (juvenile) |
| chr20_+_44420617 | 1.59 |
ENST00000449078.1
ENST00000456939.1 |
DNTTIP1
|
deoxynucleotidyltransferase, terminal, interacting protein 1 |
| chr15_-_30113676 | 1.58 |
ENST00000400011.2
|
TJP1
|
tight junction protein 1 |
| chr14_+_96722152 | 1.58 |
ENST00000216629.6
|
BDKRB1
|
bradykinin receptor B1 |
| chr15_+_76016293 | 1.57 |
ENST00000332145.2
|
ODF3L1
|
outer dense fiber of sperm tails 3-like 1 |
| chr13_+_113030625 | 1.57 |
ENST00000283550.3
|
SPACA7
|
sperm acrosome associated 7 |
| chr1_-_203274418 | 1.56 |
ENST00000457348.1
|
RP11-134P9.1
|
long intergenic non-protein coding RNA 1136 |
| chr17_-_8055747 | 1.55 |
ENST00000317276.4
ENST00000581703.1 |
PER1
|
period circadian clock 1 |
| chr11_+_28129795 | 1.55 |
ENST00000406787.3
ENST00000342303.5 ENST00000403099.1 ENST00000407364.3 |
METTL15
|
methyltransferase like 15 |
| chr11_-_71159380 | 1.55 |
ENST00000525346.1
ENST00000531364.1 ENST00000529990.1 ENST00000527316.1 ENST00000407721.2 |
DHCR7
|
7-dehydrocholesterol reductase |
| chr15_-_72612470 | 1.54 |
ENST00000287202.5
|
CELF6
|
CUGBP, Elav-like family member 6 |
| chr11_-_71159458 | 1.53 |
ENST00000355527.3
|
DHCR7
|
7-dehydrocholesterol reductase |
| chr12_+_43086018 | 1.52 |
ENST00000550177.1
|
RP11-25I15.3
|
RP11-25I15.3 |
| chr12_+_18891045 | 1.49 |
ENST00000317658.3
|
CAPZA3
|
capping protein (actin filament) muscle Z-line, alpha 3 |
| chr3_-_124774802 | 1.48 |
ENST00000311127.4
|
HEG1
|
heart development protein with EGF-like domains 1 |
| chr12_-_109219937 | 1.47 |
ENST00000546697.1
|
SSH1
|
slingshot protein phosphatase 1 |
| chr18_-_5540471 | 1.47 |
ENST00000581833.1
ENST00000544123.1 ENST00000342933.3 ENST00000400111.3 ENST00000585142.1 |
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3 |
| chr2_+_87769459 | 1.47 |
ENST00000414030.1
ENST00000437561.1 |
LINC00152
|
long intergenic non-protein coding RNA 152 |
| chr11_-_63439013 | 1.47 |
ENST00000398868.3
|
ATL3
|
atlastin GTPase 3 |
| chr8_-_27115903 | 1.46 |
ENST00000350889.4
ENST00000519997.1 ENST00000519614.1 ENST00000522908.1 ENST00000265770.7 |
STMN4
|
stathmin-like 4 |
| chr19_+_6739662 | 1.46 |
ENST00000313285.8
ENST00000313244.9 ENST00000596758.1 |
TRIP10
|
thyroid hormone receptor interactor 10 |
| chr12_+_75874580 | 1.46 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chr8_+_38243951 | 1.46 |
ENST00000297720.5
|
LETM2
|
leucine zipper-EF-hand containing transmembrane protein 2 |
| chr6_-_136571400 | 1.43 |
ENST00000418509.2
ENST00000420702.1 ENST00000451457.2 |
MTFR2
|
mitochondrial fission regulator 2 |
| chr7_-_129592700 | 1.42 |
ENST00000472396.1
ENST00000355621.3 |
UBE2H
|
ubiquitin-conjugating enzyme E2H |
| chr10_-_3827371 | 1.41 |
ENST00000469435.1
|
KLF6
|
Kruppel-like factor 6 |
| chr1_+_25071848 | 1.41 |
ENST00000374379.4
|
CLIC4
|
chloride intracellular channel 4 |
| chr11_+_4116005 | 1.40 |
ENST00000300738.5
|
RRM1
|
ribonucleotide reductase M1 |
| chr1_-_221915418 | 1.39 |
ENST00000323825.3
ENST00000366899.3 |
DUSP10
|
dual specificity phosphatase 10 |
| chr12_+_75874984 | 1.39 |
ENST00000550491.1
|
GLIPR1
|
GLI pathogenesis-related 1 |
| chr18_+_61554932 | 1.37 |
ENST00000299502.4
ENST00000457692.1 ENST00000413956.1 |
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
| chr3_-_99595037 | 1.37 |
ENST00000383694.2
|
FILIP1L
|
filamin A interacting protein 1-like |
| chr10_-_50342053 | 1.36 |
ENST00000311787.5
|
FAM170B
|
family with sequence similarity 170, member B |
| chr19_+_49109990 | 1.35 |
ENST00000321762.1
|
SPACA4
|
sperm acrosome associated 4 |
| chr17_-_7155274 | 1.33 |
ENST00000318988.6
ENST00000575783.1 ENST00000573600.1 |
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
| chr12_+_71833756 | 1.33 |
ENST00000536515.1
ENST00000540815.2 |
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5 |
| chr12_-_12674032 | 1.32 |
ENST00000298573.4
|
DUSP16
|
dual specificity phosphatase 16 |
| chr1_-_209957882 | 1.30 |
ENST00000294811.1
|
C1orf74
|
chromosome 1 open reading frame 74 |
| chr22_-_36357671 | 1.30 |
ENST00000408983.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
| chr12_-_4754339 | 1.29 |
ENST00000228850.1
|
AKAP3
|
A kinase (PRKA) anchor protein 3 |
| chr11_-_107582775 | 1.29 |
ENST00000305991.2
|
SLN
|
sarcolipin |
| chr11_+_4116054 | 1.27 |
ENST00000423050.2
|
RRM1
|
ribonucleotide reductase M1 |
| chr3_+_42190714 | 1.27 |
ENST00000449246.1
|
TRAK1
|
trafficking protein, kinesin binding 1 |
| chr1_+_31769836 | 1.27 |
ENST00000344147.5
ENST00000373714.1 ENST00000546109.1 ENST00000422613.2 |
ZCCHC17
|
zinc finger, CCHC domain containing 17 |
| chr7_-_121944491 | 1.26 |
ENST00000331178.4
ENST00000427185.2 ENST00000442488.2 |
FEZF1
|
FEZ family zinc finger 1 |
| chr20_+_58179582 | 1.25 |
ENST00000371015.1
ENST00000395639.4 |
PHACTR3
|
phosphatase and actin regulator 3 |
| chr2_-_183106641 | 1.24 |
ENST00000346717.4
|
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
| chr1_+_87595433 | 1.24 |
ENST00000469312.2
ENST00000490006.2 |
RP5-1052I5.1
|
long intergenic non-protein coding RNA 1140 |
| chr3_+_150126101 | 1.24 |
ENST00000361875.3
ENST00000361136.2 |
TSC22D2
|
TSC22 domain family, member 2 |
| chr16_-_10868853 | 1.24 |
ENST00000572428.1
|
TVP23A
|
trans-golgi network vesicle protein 23 homolog A (S. cerevisiae) |
| chr15_+_45879321 | 1.23 |
ENST00000220531.3
ENST00000567461.1 |
BLOC1S6
|
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin |
| chr20_+_43343517 | 1.23 |
ENST00000372865.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr3_-_47934234 | 1.22 |
ENST00000420772.2
|
MAP4
|
microtubule-associated protein 4 |
| chr10_+_80008505 | 1.21 |
ENST00000434974.1
ENST00000423770.1 ENST00000432742.1 |
LINC00856
|
long intergenic non-protein coding RNA 856 |
| chr9_-_113761720 | 1.21 |
ENST00000541779.1
ENST00000374430.2 |
LPAR1
|
lysophosphatidic acid receptor 1 |
| chr8_-_42065075 | 1.20 |
ENST00000429089.2
ENST00000519510.1 ENST00000429710.2 ENST00000524009.1 |
PLAT
|
plasminogen activator, tissue |
| chr2_-_232791038 | 1.20 |
ENST00000295440.2
ENST00000409852.1 |
NPPC
|
natriuretic peptide C |
| chr2_-_192711968 | 1.20 |
ENST00000304141.4
|
SDPR
|
serum deprivation response |
| chrX_-_119709637 | 1.18 |
ENST00000404115.3
|
CUL4B
|
cullin 4B |
| chr20_+_55099542 | 1.18 |
ENST00000371328.3
|
FAM209A
|
family with sequence similarity 209, member A |
| chr1_-_109935819 | 1.18 |
ENST00000538502.1
|
SORT1
|
sortilin 1 |
| chr19_+_18723660 | 1.17 |
ENST00000262817.3
|
TMEM59L
|
transmembrane protein 59-like |
| chr10_+_134351319 | 1.17 |
ENST00000368594.3
ENST00000368593.3 |
INPP5A
|
inositol polyphosphate-5-phosphatase, 40kDa |
| chr12_-_28125638 | 1.17 |
ENST00000545234.1
|
PTHLH
|
parathyroid hormone-like hormone |
| chr1_+_39456895 | 1.15 |
ENST00000432648.3
ENST00000446189.2 ENST00000372984.4 |
AKIRIN1
|
akirin 1 |
| chr19_-_10341948 | 1.15 |
ENST00000590320.1
ENST00000592342.1 ENST00000588952.1 |
S1PR2
DNMT1
|
sphingosine-1-phosphate receptor 2 DNA (cytosine-5-)-methyltransferase 1 |
| chr9_-_111696340 | 1.14 |
ENST00000374647.5
|
IKBKAP
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein |
| chr10_+_27444268 | 1.14 |
ENST00000375940.4
ENST00000342386.6 |
MASTL
|
microtubule associated serine/threonine kinase-like |
| chr12_-_52887034 | 1.11 |
ENST00000330722.6
|
KRT6A
|
keratin 6A |
| chr8_+_38243967 | 1.10 |
ENST00000524874.1
ENST00000379957.4 ENST00000523983.2 |
LETM2
|
leucine zipper-EF-hand containing transmembrane protein 2 |
| chr10_-_29811456 | 1.09 |
ENST00000535393.1
|
SVIL
|
supervillin |
| chr19_+_7011509 | 1.08 |
ENST00000377296.3
|
AC025278.1
|
Uncharacterized protein |
| chr11_-_2193025 | 1.08 |
ENST00000333684.5
ENST00000381178.1 ENST00000381175.1 ENST00000352909.3 |
TH
|
tyrosine hydroxylase |
| chr12_+_113344811 | 1.07 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
| chr4_-_147043058 | 1.07 |
ENST00000512063.1
ENST00000507726.1 |
RP11-6L6.3
|
long intergenic non-protein coding RNA 1095 |
Network of associatons between targets according to the STRING database.
First level regulatory network of JUN
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.3 | 12.8 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 2.8 | 8.3 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 1.7 | 5.0 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 1.6 | 9.5 | GO:0030035 | microspike assembly(GO:0030035) |
| 1.6 | 4.7 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 1.5 | 12.3 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 1.5 | 7.5 | GO:1904751 | positive regulation of telomeric DNA binding(GO:1904744) positive regulation of protein localization to nucleolus(GO:1904751) |
| 1.2 | 5.8 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.0 | 3.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.0 | 2.9 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.9 | 0.9 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.9 | 5.4 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.9 | 3.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.8 | 3.3 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.8 | 4.9 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.8 | 2.3 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.7 | 2.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.7 | 2.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.7 | 3.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.6 | 1.9 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.6 | 5.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.6 | 3.1 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.6 | 3.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.6 | 1.7 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.6 | 1.7 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
| 0.6 | 3.4 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.6 | 1.7 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.5 | 3.2 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.5 | 1.6 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.5 | 3.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.5 | 1.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.5 | 2.0 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.5 | 1.5 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.5 | 2.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.5 | 2.8 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.5 | 7.0 | GO:0000050 | urea cycle(GO:0000050) |
| 0.4 | 0.4 | GO:2000724 | positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
| 0.4 | 1.6 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.4 | 1.2 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 0.4 | 1.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.4 | 8.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.4 | 4.7 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.4 | 1.1 | GO:0042214 | terpene metabolic process(GO:0042214) phytoalexin metabolic process(GO:0052314) |
| 0.4 | 1.1 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.3 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.3 | 1.0 | GO:1901899 | dense core granule biogenesis(GO:0061110) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
| 0.3 | 2.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.3 | 3.1 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.3 | 1.2 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.3 | 1.2 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) positive regulation of protein monoubiquitination(GO:1902527) |
| 0.3 | 1.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.3 | 2.9 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.3 | 1.2 | GO:0046833 | snRNA export from nucleus(GO:0006408) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.3 | 0.6 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.3 | 1.4 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.3 | 0.8 | GO:0035698 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.3 | 1.1 | GO:0051710 | cytolysis by symbiont of host cells(GO:0001897) regulation of cytolysis in other organism(GO:0051710) |
| 0.3 | 2.7 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.3 | 0.8 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
| 0.3 | 1.3 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.3 | 1.8 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 | 5.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.2 | 1.0 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.2 | 0.7 | GO:0021896 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.2 | 2.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.2 | 0.7 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.2 | 0.9 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.2 | 1.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.2 | 0.5 | GO:0048320 | axial mesoderm formation(GO:0048320) |
| 0.2 | 4.5 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.2 | 1.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.2 | 1.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.2 | 0.6 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.2 | 1.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 | 0.6 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.2 | 0.8 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.2 | 3.1 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.2 | 1.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.2 | 0.6 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.2 | 0.8 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.2 | 3.0 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.2 | 1.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.2 | 1.9 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.2 | 0.6 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.2 | 0.9 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
| 0.2 | 0.6 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.2 | 1.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.2 | 1.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.2 | 10.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.2 | 0.7 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.2 | 3.5 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.2 | 2.1 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.2 | 2.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.2 | 3.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.2 | 1.8 | GO:0007135 | meiosis II(GO:0007135) |
| 0.2 | 0.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.2 | 1.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 | 0.8 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 | 4.0 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.2 | 0.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.2 | 1.8 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.1 | 1.8 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.1 | 0.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.1 | 0.6 | GO:0046777 | protein autophosphorylation(GO:0046777) |
| 0.1 | 1.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 | 1.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 1.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.1 | 1.4 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.1 | 0.4 | GO:0007343 | egg activation(GO:0007343) |
| 0.1 | 0.6 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.1 | 0.3 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.1 | 0.4 | GO:0039019 | pronephric nephron development(GO:0039019) |
| 0.1 | 0.7 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.1 | 0.5 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.1 | 1.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 | 0.6 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 2.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 | 3.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 0.9 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 | 0.9 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 | 0.4 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.1 | 1.0 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.1 | 2.7 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 | 1.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 | 0.4 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 | 1.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 | 1.3 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.1 | 1.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 | 0.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.1 | 3.4 | GO:0000732 | strand displacement(GO:0000732) |
| 0.1 | 0.5 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.1 | 0.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.1 | 0.3 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.1 | 1.7 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.1 | 1.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 0.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 | 1.4 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.1 | 1.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
| 0.1 | 8.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 1.2 | GO:0006970 | response to osmotic stress(GO:0006970) |
| 0.1 | 0.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 0.3 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 | 0.7 | GO:0032202 | telomere assembly(GO:0032202) |
| 0.1 | 0.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.1 | 0.2 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
| 0.1 | 0.3 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.1 | 1.9 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 | 0.5 | GO:2000147 | positive regulation of cell migration(GO:0030335) positive regulation of locomotion(GO:0040017) positive regulation of cell motility(GO:2000147) |
| 0.1 | 1.8 | GO:0051197 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.1 | 0.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 | 1.8 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 | 0.3 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.1 | 1.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 1.0 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 3.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 | 1.1 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 0.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.1 | 0.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 | 1.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 | 0.3 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 0.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 1.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 0.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 | 2.0 | GO:0007567 | parturition(GO:0007567) |
| 0.1 | 0.6 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 0.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 | 1.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 0.6 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 | 1.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.9 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
| 0.1 | 0.9 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.1 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.1 | 0.1 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.1 | 2.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 0.2 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) cellular response to peptidoglycan(GO:0071224) |
| 0.1 | 3.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 1.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.1 | 1.8 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.1 | 0.9 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.1 | 0.4 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.1 | 1.9 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.1 | 0.3 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
| 0.1 | 0.3 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.1 | 4.5 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 0.3 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.1 | 1.8 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 | 0.6 | GO:0043065 | positive regulation of apoptotic process(GO:0043065) positive regulation of programmed cell death(GO:0043068) |
| 0.0 | 0.4 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 | 0.1 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.0 | 0.8 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.0 | 0.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 1.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.0 | 0.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 | 0.2 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.0 | 0.4 | GO:0051493 | regulation of cytoskeleton organization(GO:0051493) |
| 0.0 | 0.9 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.0 | 0.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.0 | 1.7 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.0 | 0.5 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.0 | 0.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 | 12.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.0 | 0.7 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.0 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.0 | 0.4 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.0 | 0.1 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.0 | 0.7 | GO:0030728 | ovulation(GO:0030728) |
| 0.0 | 0.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.0 | 0.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 0.7 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.0 | 1.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 0.0 | 0.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 | 2.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.0 | 1.0 | GO:0006468 | protein phosphorylation(GO:0006468) |
| 0.0 | 1.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.0 | 0.4 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.0 | 1.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.0 | 2.7 | GO:0007588 | excretion(GO:0007588) |
| 0.0 | 1.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 0.2 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
| 0.0 | 0.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 | 0.3 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.0 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 | 0.5 | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway(GO:0007169) |
| 0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.0 | 1.5 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
| 0.0 | 1.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 | 0.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.8 | GO:0097503 | sialylation(GO:0097503) |
| 0.0 | 2.1 | GO:0007399 | nervous system development(GO:0007399) |
| 0.0 | 3.1 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.0 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.0 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 | 0.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.0 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
| 0.0 | 0.4 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.0 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 0.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 | 0.8 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
| 0.0 | 1.0 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
| 0.0 | 0.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.0 | 0.0 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
| 0.0 | 0.5 | GO:0016577 | histone demethylation(GO:0016577) |
| 0.0 | 3.7 | GO:0006986 | response to unfolded protein(GO:0006986) |
| 0.0 | 0.5 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 | 0.9 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 1.4 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.0 | 0.6 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
| 0.0 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 2.2 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.0 | 0.0 | GO:0043449 | olfactory learning(GO:0008355) cellular alkene metabolic process(GO:0043449) |
| 0.0 | 0.7 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
| 0.0 | 0.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.0 | 0.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 | 0.0 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
| 0.0 | 0.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.0 | 1.3 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 0.0 | 3.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 | 0.7 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
| 0.0 | 0.3 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.0 | 0.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 | 0.2 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 | 0.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.0 | 0.9 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.0 | 1.1 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 | 0.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.3 | GO:0051262 | protein tetramerization(GO:0051262) |
| 0.0 | 0.4 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.0 | 0.3 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.0 | 0.6 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.0 | 0.4 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.0 | 1.2 | GO:0045995 | regulation of embryonic development(GO:0045995) |
| 0.0 | 1.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 5.8 | GO:0031523 | Myb complex(GO:0031523) |
| 1.5 | 4.4 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
| 1.0 | 3.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.0 | 3.1 | GO:0097447 | dendritic tree(GO:0097447) |
| 1.0 | 12.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 1.0 | 4.8 | GO:0044393 | microspike(GO:0044393) |
| 1.0 | 2.9 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.9 | 2.8 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
| 0.8 | 6.8 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.6 | 2.3 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.6 | 7.9 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.5 | 2.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.4 | 1.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.4 | 2.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.4 | 2.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.3 | 4.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.3 | 1.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.3 | 2.1 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.3 | 2.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.3 | 1.2 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.3 | 18.4 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.3 | 3.5 | GO:0070938 | contractile ring(GO:0070938) |
| 0.3 | 0.8 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.2 | 3.2 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.2 | 1.7 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.2 | 1.8 | GO:0071546 | pi-body(GO:0071546) |
| 0.2 | 3.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.2 | 3.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.2 | 2.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.2 | 4.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.2 | 14.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.2 | 1.7 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.2 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.2 | 0.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.1 | 1.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.1 | 0.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.1 | 1.7 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.1 | 1.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.1 | 1.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.1 | 0.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.1 | 0.4 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.1 | 2.4 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 0.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.1 | 1.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 10.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.1 | 0.6 | GO:0033503 | HULC complex(GO:0033503) |
| 0.1 | 0.2 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.1 | 3.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 0.6 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.1 | 1.5 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.1 | 4.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.1 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 2.2 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 5.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 4.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.1 | 5.0 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 0.7 | GO:0070187 | telosome(GO:0070187) |
| 0.1 | 1.5 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.1 | 1.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 6.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 0.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.0 | 0.8 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.0 | 1.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.0 | 1.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.0 | 0.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.0 | 1.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 0.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.0 | 1.1 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.0 | 3.6 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.0 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.0 | 0.8 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.0 | 1.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 1.8 | GO:0031430 | M band(GO:0031430) |
| 0.0 | 3.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.0 | 0.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 3.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.0 | 0.9 | GO:0030904 | retromer complex(GO:0030904) |
| 0.0 | 0.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.0 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.0 | 0.4 | GO:0060076 | excitatory synapse(GO:0060076) |
| 0.0 | 1.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 1.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.0 | 3.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 3.9 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 0.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.0 | 0.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.0 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 7.4 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.0 | 1.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.0 | 1.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 5.6 | GO:0031968 | organelle outer membrane(GO:0031968) |
| 0.0 | 0.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 0.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 1.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 0.5 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.0 | 1.0 | GO:0000786 | nucleosome(GO:0000786) |
| 0.0 | 1.0 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 1.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.0 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.0 | 0.6 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.0 | 3.2 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.0 | 0.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 1.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 0.8 | GO:0005769 | early endosome(GO:0005769) |
| 0.0 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.0 | 1.1 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.0 | 1.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.0 | 7.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 7.6 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 0.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.0 | 0.0 | GO:0031082 | BLOC complex(GO:0031082) |
| 0.0 | 0.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.0 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 1.6 | 8.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 1.2 | 5.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 1.0 | 2.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.9 | 3.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.9 | 8.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.9 | 3.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.8 | 8.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.7 | 7.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.6 | 1.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.6 | 1.7 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.6 | 1.7 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 0.6 | 2.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.6 | 1.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.5 | 2.7 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.5 | 2.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.5 | 2.8 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.5 | 1.8 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.4 | 1.8 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.4 | 1.3 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
| 0.4 | 5.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.3 | 3.1 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.3 | 3.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.3 | 2.3 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 0.3 | 3.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.3 | 0.9 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 0.3 | 5.0 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.3 | 5.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.3 | 1.5 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.2 | 1.2 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.2 | 3.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.2 | 3.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.2 | 2.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.2 | 0.6 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.2 | 0.6 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.2 | 5.2 | GO:0043495 | protein anchor(GO:0043495) |
| 0.2 | 12.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 2.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.2 | 12.8 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.2 | 3.1 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.2 | 1.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.2 | 4.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.2 | 0.5 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.2 | 1.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.2 | 1.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.2 | 1.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.2 | 1.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.2 | 1.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.2 | 2.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.2 | 1.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.2 | 2.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.2 | 0.5 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.1 | 0.9 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.1 | 0.4 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
| 0.1 | 4.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 14.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 1.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.1 | 0.4 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.1 | 3.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 2.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 1.2 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 2.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 1.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.1 | 4.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 14.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 1.0 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.1 | 0.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.1 | 2.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 0.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.1 | 0.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 3.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.1 | 4.7 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 0.3 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.1 | 2.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 2.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.1 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 1.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 1.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 0.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.1 | 2.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.1 | 2.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 3.1 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.1 | 0.3 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
| 0.1 | 2.0 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.1 | 0.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 0.3 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.1 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 1.7 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
| 0.1 | 0.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.1 | 1.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.1 | 6.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 3.8 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 0.3 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.1 | 0.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.1 | 0.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.1 | 0.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.1 | 3.5 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 0.2 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.1 | 0.9 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.1 | 1.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 1.6 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 3.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.1 | 1.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 0.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.1 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 4.1 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.1 | 0.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
| 0.0 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.0 | 4.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.0 | 3.3 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.0 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.0 | 0.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.0 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.0 | 0.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 1.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 4.5 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.0 | 1.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.0 | 0.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.0 | 0.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.0 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.0 | 7.7 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 0.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 0.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 1.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 0.4 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.0 | 2.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 0.5 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
| 0.0 | 3.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 1.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.0 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.0 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.0 | 1.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 0.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.0 | 1.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.0 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 1.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 1.1 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.0 | 0.1 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 0.0 | 0.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.0 | 0.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.0 | 0.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.0 | 0.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 0.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.0 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 7.0 | GO:0003779 | actin binding(GO:0003779) |
| 0.0 | 0.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.0 | 0.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.0 | 0.9 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
| 0.0 | 0.7 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.0 | 6.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.0 | 2.2 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 0.6 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.0 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.0 | 0.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.1 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.0 | 0.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.0 | 0.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.0 | 1.4 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.0 | 2.7 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.0 | 8.0 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 2.6 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.0 | 0.1 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.0 | 0.7 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.0 | 1.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.0 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.0 | 0.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.0 | 2.3 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 12.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.3 | 9.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.2 | 11.4 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 4.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.2 | 4.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 4.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 8.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 13.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 5.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 4.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 1.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 1.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 1.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 3.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 2.9 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 4.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 1.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.1 | 3.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 2.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 2.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 2.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 2.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 1.8 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.1 | 1.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 1.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 5.2 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 0.9 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.0 | 3.3 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 2.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.0 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.0 | 3.2 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 2.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 1.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 0.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 1.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 1.0 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 1.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.0 | 0.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.0 | 1.8 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 0.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 1.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.0 | 1.5 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 8.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 0.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.0 | 1.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 0.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 1.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 1.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 0.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 12.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.4 | 13.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.3 | 5.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 4.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.2 | 2.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.2 | 1.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.2 | 5.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.2 | 11.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.2 | 3.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.2 | 3.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 5.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 2.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.1 | 1.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.1 | 3.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.1 | 4.3 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.1 | 3.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 2.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.1 | 2.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 1.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 2.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 4.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.1 | 3.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 4.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 1.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 2.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 0.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.1 | 1.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 0.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.1 | 2.0 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
| 0.1 | 0.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 0.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.0 | 2.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 2.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 1.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.0 | 1.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.0 | 5.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.0 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.0 | 0.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.0 | 0.9 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
| 0.0 | 2.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 1.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.0 | 0.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.0 | 7.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 3.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.0 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 0.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.0 | 0.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.0 | 2.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 2.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 0.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 2.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.0 | 0.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 1.0 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.0 | 2.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 1.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.0 | 0.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 0.6 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
| 0.0 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 1.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 3.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 0.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.0 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 0.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 2.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |